Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001680739-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | May 21, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
16,000
Total Value
$0.00
P&L
+inf% (+$881,760.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 19, 2026 | Grant/Award | 4,000 | $0.00 | $0.00 | 41,500 | Direct | โ | View Details | |
Director | Stock option (right to buy) | Derivative | May 19, 2026 | Grant/Award | 12,000 | $0.00 | $0.00 | 12,000 | Direct | โ | View Details |